CENTOGENE Explores Strategic Alternatives
CentogeneCentogene(US:CNTG) Newsfilter·2024-02-28 11:30

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (NASDAQ:CNTG) (the "Company"), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced that the Company has decided to explore a range of strategic alternatives focused on sustainable long-term value creation for the benefit of its stakeholders. "CENTOGENE is recognized as the world leader in rare and complex disease diagnostics, data, and pharma servi ...